Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024
29 Julio 2024 - 3:05PM
Business Wire
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its
novel and proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™)
technology, today announced it will report financial results for
the second quarter 2024 after market close on Monday, August 12,
2024. Company management will host a corresponding conference call
beginning at 1:30pm PT / 4:30pm ET.
Investors interested in listening to the conference call may do
so by dialing 1-877-704-4453 for domestic callers or 1-201-389-0920
for international callers. A live and recorded webcast of the event
will be available at http://investors.pulsebiosciences.com/.
About Pulse Biosciences®
Pulse Biosciences is a novel bioelectric medicine company
committed to health innovation that has the potential to improve
the quality of life for patients. The Company’s proprietary CellFX®
nsPFA™ technology delivers nanosecond pulses of electrical energy
to non-thermally clear cells while sparing adjacent noncellular
tissue. The Company is actively pursuing the development of its
CellFX nsPFA technology for use in the treatment of atrial
fibrillation and in a select few other markets where it could have
a profound positive impact on healthcare for both patients and
providers. Pulse Biosciences is now headquartered in Miami, Florida
and maintains its office in Hayward, California.
Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA,
CellFX nsPFA and the stylized logos are among the trademarks and/or
registered trademarks of Pulse Biosciences, Inc. in the United
States and other countries.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240729277595/en/
Investors: Pulse Biosciences, Inc. Burke T. Barrett,
President and CEO IR@pulsebiosciences.com
Or
Gilmartin Group Philip Trip Taylor 415.937.5406
philip@gilmartinir.com
Pulse Biosciences (NASDAQ:PLSE)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Pulse Biosciences (NASDAQ:PLSE)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024